skip to Main Content
 

Three Quick Facts: Oxford Biomedica, Helium One Global and LoopUp

*

Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Oxford Biomedica sign three new customers

There’s a definite air of pre-Christmas calm in the news releases this morning, but Oxford Biomedica [LON:OXB] have announced the formation of three new partnerships with biotech companies. This means OXB is providing platforms to support the partners’ pre-clinical gene therapy programs. That means the company has secured four new “AAV” customers this year, materially ahead of the forecast of two client wins.

#2. Helium One Global fundraising extended amidst popular appeal

Helium One Global [LON:HE1] has provided an update on its fundraise, announcing that as a result of investor demand the scale has been extended to £9.9 million, with the additional funds providing greater working capital flexibility following the proposed Q1 ’23 drilling program.

#3. LoopUp trading update shows revenues up, EBITDA down

AIM-listed LoopUp [LON:LOOP], the cloud platform for hybrid communications, has this morning issued a trading update. Following the successful integration of customers from PGI Connect, the company now expects full year revenues to be marginally ahead of expectations at no less than £15.5m. FY EBITDA will however be impacted by higher transition execution costs, but this is seen as a one off and won’t weigh on FY23 profitability. Management note that the increase in run rate leaves the company well positioned to see further growth next year.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

In-depth Reports

Detailed reviews of selected companies and investment trusts.

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
FP Markets
IG
Pepperstone
WisdomTree
CME Group
Back To Top